Red Capital's Life Science and Healthcare Fund 'Red No. 1 Healthcare Investment Limited Partnership' Welcomes Organization for Small & Medium Enterprises and Regional Innovation (SME Support JAPAN) — Accelerating Fund Expansion and Ecosystem Collaboration
NQ Score
50/100
AI Summary (NQ-processed)
SME Support JAPAN joins Red Capital's healthcare-focused fund, accelerating the fund's growth and ecosystem development.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Who recently joined as a limited partner in the Red No. 1 Healthcare Investment Limited Partnership?
- A: The Organization for Small & Medium Enterprises and Regional Innovation, also known as SME Support JAPAN, joined as a limited partner.
- Q: What is the target fund size that Red Capital is continuing its fundraising activities to reach?
- A: The target fund size for the Red No. 1 Healthcare Investment Limited Partnership is six billion yen.
- Q: What are the two investment approaches combined by the Red No. 1 Healthcare Investment Limited Partnership?
- A: The fund combines a Seed-Drive model for seed-to-exit support and an Ecosystem-Complementary model for secondary investments.
- Q: What is the primary vision under which Red Capital established the Red No. 1 Healthcare Investment Limited Partnership?
- A: The fund was established under the vision of taking humanity to the next stage by bridging science and technology with social implementation.
- Q: Which financial institutions and organizations are currently included as limited partners in the Red No. 1 Fund?
- A: The LPs include SME Support JAPAN, Seibu Shinkin Bank, the University-based Startup Promotion Fund, and The Shizuoka Bank, Ltd.